Exploitation of elevated pyrimidine deaminating enzymes for selective chemotherapy.
Boothman
D A
DA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115.
Briggle
T V
TV
Greer
S
S
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003641:Deamination; D011743:Pyrimidines / Q000378:metabolism*; D000637:Transaminases / Q000378:metabolism*
D000970:Antineoplastic Agents; D011743:Pyrimidines; D000637:Transaminases